SoftOx Solutions AS (SOFTX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SoftOx Solutions AS (SOFTX) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr287.00K ≈ $30.20K USD) by net assets (Nkr100.26 Million ≈ $10.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SoftOx Solutions AS - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how SoftOx Solutions AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SoftOx Solutions AS (SOFTX) financial obligations for a breakdown of total debt and financial obligations.
SoftOx Solutions AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SoftOx Solutions AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mindax Ltd
AU:MDX
|
-0.040x |
|
Lung Hwa Electronics Co Ltd
TW:2424
|
-0.057x |
|
AQUA SA ZY 16
F:9S0
|
0.019x |
|
nTels Co. Ltd
KQ:069410
|
-0.030x |
|
Kein Hing International Bhd
KLSE:7199
|
0.151x |
|
9F Inc
NASDAQ:JFU
|
0.038x |
|
Senetas Corporation Ltd
AU:SEN
|
-0.024x |
|
Next Science Ltd
AU:NXS
|
2.498x |
Annual Cash Flow Conversion Efficiency for SoftOx Solutions AS (2017–2024)
The table below shows the annual cash flow conversion efficiency of SoftOx Solutions AS from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see SOFTX market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr95.18 Million ≈ $10.02 Million |
Nkr32.56 Million ≈ $3.43 Million |
0.342x | +6.98% |
| 2023-12-31 | Nkr2.37 Million ≈ $249.01K |
Nkr756.68K ≈ $79.62K |
0.320x | +105.96% |
| 2022-12-31 | Nkr16.01 Million ≈ $1.68 Million |
Nkr-85.94 Million ≈ $-9.04 Million |
-5.369x | -557.42% |
| 2021-12-31 | Nkr88.85 Million ≈ $9.35 Million |
Nkr-72.56 Million ≈ $-7.64 Million |
-0.817x | -3.07% |
| 2020-12-31 | Nkr76.22 Million ≈ $8.02 Million |
Nkr-60.39 Million ≈ $-6.35 Million |
-0.792x | -548.68% |
| 2019-12-31 | Nkr86.47 Million ≈ $9.10 Million |
Nkr-10.56 Million ≈ $-1.11 Million |
-0.122x | +88.22% |
| 2018-12-31 | Nkr14.41 Million ≈ $1.52 Million |
Nkr-14.94 Million ≈ $-1.57 Million |
-1.037x | -81.43% |
| 2017-12-31 | Nkr26.85 Million ≈ $2.83 Million |
Nkr-15.34 Million ≈ $-1.61 Million |
-0.571x | -- |
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more